Cost Effectiveness of Glargine Insulin Versus NPH Insulin

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT01832935

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose basic science
Phase
Phase 4
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01832935
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Iran (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01832935. Randomized; double masking; primary purpose basic science. Start 2011-07 (registry gives no type); primary completion 2012-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cost Effectiveness of Glargine Insulin Versus NPH Insulin
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
insulin glargine
Intervention (Drug)
Insulin NPH
Lead sponsor
Tehran University of Medical Sciences (class: other)

Record details

Record id
cardio:ct-nct01832935
Content hash
4fc413f8a8a1fba6c243a60a7eac922cffbe91f0e9cd2c50d04a3f5232e5bb94